4.6 Article

Advancements in the development of subunit influenza vaccines

Journal

MICROBES AND INFECTION
Volume 17, Issue 2, Pages 123-134

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.micinf.2014.12.006

Keywords

Influenza A virus; Subunit vaccines; Nucleoprotein; Matrix protein; Hemagglutinin

Funding

  1. National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R21AI111152]
  2. Chinese Ministry of Science & Technology, Hong Kong, Macau, Taiwan Collaborative Program [201200007673]
  3. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI111152] Funding Source: NIH RePORTER

Ask authors/readers for more resources

The ongoing threat of influenza epidemics and pandemics has emphasized the importance of developing safe and effective vaccines against infections from divergent influenza viruses. In this review, we first introduce the structure and life cycle of influenza A viruses, describing major influenza A virus-caused pandemics. We then compare different types of influenza vaccines and discuss current advancements in the development of subunit influenza vaccines, particularly those based on nucleoprotein (NP), extracellular domain of matrix protein 2 (M2e) and hemagglutinin (HA) proteins. We also illustrate potential strategies for improving the efficacy of subunit influenza vaccines. (C) 2014 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available